Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Polyfins Technology
AddedFeb 18, 2024
UpdatedJun 18, 2026
Polyfins Technology

Polyfins Technology

Digital provider of therapeutic apps for chronic skin diseases.

HQ
Fremont, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Polyfins Technology Inc, founded in Texas, is dedicated to revolutionizing chronic skin care through the application of Artificial Intelligence. Their core mission is to enhance the accessibility and accuracy of dermatological care for patients globally, leveraging mobile technology and AI. Polyfins offers digital therapeutic apps specifically designed to manage chronic skin diseases, providing a user-friendly interface for both patients and healthcare providers.

Notable figures associated with Polyfins Technology include experts in AI and dermatology, although specific names are not mentioned. The company has achieved significant milestones in improving patient care through its innovative approach, making a substantial impact on the accessibility of dermatological treatments. By integrating advanced AI solutions, Polyfins Technology is setting new standards in the digital health sector, particularly in the management of chronic skin conditions.

Polyfins Technology - Similar Companies

Polyremedy logo

Polyremedy

Piction Health logo

Piction Health

lumindx.com

Skintelligent Corporation logo

Skintelligent Corporation

Digi-Prex logo

Digi-Prex

digi-prex.com

Treatment Technologies & Insights logo

Treatment Technologies & Insights

tti.care

FirstDerm logo

FirstDerm

firstderm.com

Renalis logo

Renalis

renalis.health

CureSkin logo

CureSkin

cureskin.com

Pear Therapeutics logo

Pear Therapeutics

Distinct Dermatology logo

Distinct Dermatology

NewTouch Digital logo

NewTouch Digital

Theratec logo

Theratec

theratec.com

Polybiotics logo

Polybiotics

MicroHealth logo

MicroHealth

microhealth.com

Luminopia logo

Luminopia

luminopia.com

Polyfins Technology - Quick Facts

Who are Polyfins Technology's competitors?

Companies similar to Polyfins Technology include Polyremedy, Piction Health, Skintelligent Corporation and Digi-Prex.

When was Polyfins Technology founded?

Polyfins Technology was founded in 2017.

Where is Polyfins Technology's headquarters located?

Polyfins Technology's headquarters is located in Fremont, CA, US.

When was Polyfins Technology's last funding round?

Polyfins Technology's most recent funding round was for $175k (USD) in May 2018.

How much has Polyfins Technology raised to-date?

As of May 1, 2018, Polyfins Technology has raised a total of $175k (USD).

How many employees does Polyfins Technology have?

Polyfins Technology has 5 employees as of Feb 4, 2024.

Polyfins Technology - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Therapeutic Apps
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified